Flex Pharma’s Competitors, Revenue, Number of Employees, Funding, Acquisitions & News

Flex Pharma is a clinical-stage biotechnology company that provides novel treatments for neuromuscular disorders. Read more

Flex Pharma is a clinical-stage biotechnology company that provides novel treatments for neuromuscular disorders. Read more

William K McVicar's photo - President & CEO of Flex Pharma

President & CEO

William K McVicar

CEO Approval Rating

69/100

Founded:

2014

Status:

PublicNASDAQSLRX

TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Missing a competitor? Contribute!

Brainstorm Cell Therapeutics Inc. is perceived as one of Flex Pharma's biggest rivals. Brainstorm Cell Therapeutics Inc.'s headquarters is in New York, New York, and was founded in 2000. Brainstorm Cell Therapeutics Inc. operates in the Biotechnology industry. Brainstorm Cell Therapeutics Inc. generates 43% of Flex Pharma's revenue.

Prana Biotechnology has been one of Flex Pharma's top competitors. Prana Biotechnology is a Public company that was founded in 1997 in Parkville, Victoria. Prana Biotechnology operates in the Pharmaceuticals industry. Compared to Flex Pharma, Prana Biotechnology has 7 more employees.

NeuroNascent is Flex Pharma's #3 rival. NeuroNascent was founded in Clarksville, Maryland} in 2004. NeuroNascent is in the Biotechnology industry. Compared to Flex Pharma, NeuroNascent generates $1.3M less revenue.

Weigh-in!

Help the Owler community know more

Competitor - 1/1

Is Semma Therapeutics a competitor of Flex Pharma?

Quarterly and Annual Revenue

Trailing 12-Months Trend (TTM)

Annual Revenue

$2.3M

Flex Pharma's revenue is the ranked 3rd among it's top 10 competitors. The top 10 competitors average 67.4M. Over the last two quarters, Flex Pharma's revenue has decreased by 12.4%. Specifically, in Q1 2020's revenue was $1.1M; in Q4 2019, it was $1.3M.

Acquisitions

No recent acquisitions found related to Flex Pharma

Flex Pharma Funding History

$56.2M$142.6M

Since Flex Pharma was founded in 2014, it has participated in 3 rounds of funding. In total Flex Pharma has raised $142.6M. Flex Pharma's last funding round was on Jan 2015 for a total of $86.4M

ROUND

FUNDING DATE

AMOUNT

INVESTORS

IPO
Jan 2015
$86.4M

Equity
Sep 2014
$40M
Equity
Jul 2014
$16.2M

Since Flex Pharma was founded in 2014, it has participated in 3 rounds of funding. In total Flex Pharma has raised $142.6M. Flex Pharma's last funding round was on Jan 2015 for a total of $86.4M

Investments

No recent investments found related to Flex Pharma

Flex Pharma News

May 1, 2019BioPortfolio

Flex Pharma Reports First Quarter 2019 Financial Results

Flex Pharma Inc. NASDAQ FLKS today announced its financial results for the three months ended March 3... See more »
March 6, 2019BioPortfolio

Flex Pharma Reports Fourth Quarter and Fiscal 2018 Financial Results

Flex Pharma Inc. NASDAQ FLKS today announced its financial results for the three months and fiscal ye... See more »
February 28, 2019Houston Mirror

Houston oncology co. aims to grow after merger announcement - Houston Business Journal

Houston oncology co. aims to grow after merger announcement Houston Business Journal Houston-based Sa... See more »
January 4, 2019The Business Journals

Houston oncology co. to merge with Boston's struggling Flex Pharma

Houston-based Salarius Pharmaceuticals LLC, a clinical-stage oncology company, will merge with Boston... See more »
December 9, 2018BioPortfolio

Flex Pharma Inc FLKS Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 08112018 Prices from USD $250

SummaryFlex Pharma Inc Flex Pharma is a clinicalstage biotechnology company that offers discovery and... See more »
November 5, 2018BioPortfolio

Flex Pharma Reports Third Quarter 2018 Financial Results

Flex Pharma Inc. NASDAQ FLKS today announced its financial results for the three months ended Septemb... See more »
August 20, 20184-traders

The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Flex Pharma, Inc. and Encourages Investors with Losses to Contact the Firm

(marketscreener.com) LOS ANGELES, CA / ACCESSWIRE / August 20, 2018 / The Schall Law Firm, a national... See more »

Flex Pharma Press Releases

January 4, 2019LDmicro

Flex Pharma and Salarius Pharmaceuticals Announce Merger Agreement to Accelerate Clinical Development of Novel Epigenetic Therapy for Cancer

Flex Pharma, Inc. (NASDAQ: FLKS), and Salarius Pharmaceuticals, LLC, a clinical-stage oncology compan... See more »
July 9, 2018GlobalNewswire

Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

NEW YORK, July 09, 2018 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP announces that class action lawsuit... See more »
July 9, 2018University Chronicle

Lawsuit Alleges Misleading Statements by Flex Pharma, Inc.

A lawsuit was filed on behalf of investors in Flex Pharma, Inc. (NASDAQ:FLKS) shares over alleged sec... See more »
June 22, 2018GlobalNewswire

Levi & Korsinsky, LLP Notifies Shareholders of Flex Pharma, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of August 20, 2018 - FLKS

NEW YORK, June 22, 2018 (GLOBE NEWSWIRE) -- The following statement is being issued by Levi & Korsins... See more »
April 18, 2016Business Wire

Flex Pharma's Positive Human NLC Study Selected for Presentation at AAN Annual Meeting

BOSTON--(BUSINESS WIRE)--Click to Tweet Flex Pharma, Inc. (NASDAQ: FLKS) announced that results from ... See more »
December 9, 2015Business Wire

Flex Pharma Presents at the 26th International Symposium on ALS/MND

BOSTON--(BUSINESS WIRE)--Click to Tweet this News Flex Pharma, Inc. (NASDAQ: FLKS), a biotechnology c... See more »
November 24, 2015BUSINESS WIRE

Flex Pharma Presenting at Two Upcoming Healthcare Investor Conferences in December 2015

BOSTON--(BUSINESS WIRE)--Flex Pharma, Inc. (NASDAQ: FLKS), a biotechnology company that is developing... See more »

Flex Pharma Videos

Social Statistics

Headquarters

800 Boylston St 24th Floor

Boston, Massachusetts02199

617-874-1821

Driving Directions »

Trending Companies

Summary

ABOUT

Overview

Flex Pharma is a clinical-stage biotechnology company that provides novel treatments for neuromuscular disorders. Flex Pharma was founded in 2014. Flex Pharma's headquarters is located in Boston, Massachusetts, USA 02199. It has raised 142.6M in 3 rou...

CEO

Flex Pharma's President & CEO, William K McVicar, currently has an approval rating of 69%. Flex Pharma's primary competitors are Brainstorm Cell Therapeutics Inc., Prana Biotechnology & NeuroNascent.

Website

flex-pharma.com

Frequently Asked Questions about Flex Pharma

  1. When was Flex Pharma founded?

    Flex Pharma was founded in 2014
  2. Who is Flex Pharma's CEO?

    Flex Pharma's CEO is William K McVicar
  3. How much revenue does Flex Pharma generate?

    Flex Pharma generates $2.3M in revenue
  4. How much funding does Flex Pharma have?

    Flex Pharma has historically raised $142.6M in funding
  1. Where is Flex Pharma's headquarters?

    Flex Pharma's headquarters is in Boston Massachusetts, USA
  2. How many employees does Flex Pharma have?

    Flex Pharma has 7 employees
  3. What sector does Flex Pharma operate in?

    Flex Pharma is in Biotechnology
  4. Who are Flex Pharma's competitors?

    Flex Pharma's top competitors are Brainstorm Cell Therapeutics Inc., Prana Biotechnology, NeuroNascent